tiprankstipranks
Holding ARKG?
Track your performance easily

ARKG Price & Analysis

ARKG ETF Chart & Stats

Day’s Range― - ―
52-Week Range$21.97 - $38.97
Previous Close$23.98
VolumeN/A
Average Volume (3M)2.50M
AUM1.33B
NAV23.99
Expense Ratio0.75%
Holdings Count41
Beta1.81
Inception DateOct 31, 2014
Dividend YieldN/A
Shares OutstandingN/A
Standard Deviation0.12
10 Day Avg. Volume3,097,853
30 Day Avg. Volume2,500,578
Alpha-0.01

ARK Genomic Revolution ETF (ARKG) Fund Flow Chart

ARK Genomic Revolution ETF (ARKG) 1 year Net Flows: -$238M

ARKG ETF FAQ

What was ARKG’s price range in the past 12 months?
ARKG lowest ETF price was $21.97 and its highest was $38.97 in the past 12 months.
    What is the AUM of ARKG?
    As of Apr 23, 2024 The AUM of ARKG is 1.33B.
      Is ARKG overvalued?
      According to Wall Street analysts ARKG’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does ARKG pay dividends?
        ARKG pays a Annually dividend of $0.38 which represents an annual dividend yield of N/A. See more information on ARKG dividends here
          How many shares outstanding does ARKG have?
          Currently, no data Available
          Which hedge fund is a major shareholder of ARKG?
          Among the largest hedge funds holding ARKG’s share is ARK Investment Management LLC. It holds ARKG’s shares valued at 301K.

            ARKG ETF Smart Score

            For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.​

            Top 10 Holdings

            Name
            Weight %
            Crispr Therapeutics
            7.27%
            Twist Bioscience
            6.64%
            Exact Sciences Corp
            5.47%
            Recursion Pharmaceuticals, Inc
            5.24%
            Schrodinger, Inc.
            4.63%
            Ionis Pharmaceuticals Inc.
            4.34%
            Accolade, Inc.
            3.89%
            Intellia Therapeutics Inc
            3.84%
            Beam Therapeutics, Inc.
            3.74%
            Arcturus Therapeutics
            3.64%
            Total48.69%

            ETF Description

            ARK Genomic Revolution ETF

            ARKG is an actively managed fund that targets companies involved in the genomics industry.
            Sector
            Sector
            Asset Class
            Equity
            Region
            Global
            Issuer
            ARK
            Index Tracked
            No Underlying Index
            Ticker Symbol
            ARKG
            Popular ETFs
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis